These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 11435018

  • 1. Dehydroepiandrosterone replacement in addison's disease.
    Kim SS, Brody KH.
    Eur J Obstet Gynecol Reprod Biol; 2001 Jul; 97(1):96-7. PubMed ID: 11435018
    [Abstract] [Full Text] [Related]

  • 2. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease.
    Gebre-Medhin G, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):775-80. PubMed ID: 10848883
    [Abstract] [Full Text] [Related]

  • 3. [Therapy of Addison's disease].
    Tiede N, Hofbauer LC, Bornstein SR, Kirch W.
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1561-2. PubMed ID: 20665422
    [No Abstract] [Full Text] [Related]

  • 4. Addison's disease.
    Swyer GI.
    Br Med J; 1979 Jul 07; 2(6181):25-6. PubMed ID: 223716
    [No Abstract] [Full Text] [Related]

  • 5. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec 07; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 6. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.
    Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2008 Feb 07; 93(2):400-9. PubMed ID: 18000094
    [Abstract] [Full Text] [Related]

  • 7. [Addison's disease : Primary adrenal insufficiency].
    Pulzer A, Burger-Stritt S, Hahner S.
    Internist (Berl); 2016 May 07; 57(5):457-69. PubMed ID: 27129928
    [Abstract] [Full Text] [Related]

  • 8. A case of Addison's disease associated with the Lambert-Eaton myasthenic syndrome.
    Ozata M, Odabasi Z, Musabak U, Corakci A, Gundogan MA.
    J Endocrinol Invest; 1997 Jun 07; 20(6):338-41. PubMed ID: 9294781
    [Abstract] [Full Text] [Related]

  • 9. Persistent hypersecretion of ACTH in treated Addison's disease.
    Child DF, Lewis F, Williams CP.
    J R Soc Med; 1990 Jun 07; 83(6):399-400. PubMed ID: 2166161
    [No Abstract] [Full Text] [Related]

  • 10. Quality of life in Addison's disease--the case for DHEA replacement.
    Arlt W.
    Clin Endocrinol (Oxf); 2002 May 07; 56(5):573-4. PubMed ID: 12030905
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical aspects and therapy of Addison's disease].
    Schulz F, Retiene K.
    Anasthesiol Intensivmed Prax; 1974 May 07; 9(1):139-48. PubMed ID: 4470357
    [No Abstract] [Full Text] [Related]

  • 12. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.
    Himsworth RL, Lewis JG, Rees LH.
    Clin Endocrinol (Oxf); 1978 Aug 07; 9(2):131-9. PubMed ID: 212238
    [Abstract] [Full Text] [Related]

  • 13. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B.
    J Endocrinol Invest; 2004 Sep 07; 27(8):736-41. PubMed ID: 15636426
    [Abstract] [Full Text] [Related]

  • 14. Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells.
    Coles AJ, Thompson S, Cox AL, Curran S, Gurnell EM, Chatterjee VK.
    Eur J Immunol; 2005 Dec 07; 35(12):3694-703. PubMed ID: 16252254
    [Abstract] [Full Text] [Related]

  • 15. [Familial Addison's disease. Adrenocortical insufficiency in 4 brothers, and several probable cases in 2 generations of the same family].
    Bamatter F, Koegel R, de Haller J, Muller AF.
    Helv Paediatr Acta; 1966 Jun 07; 21(2):109-52. PubMed ID: 4295641
    [No Abstract] [Full Text] [Related]

  • 16. [Addison's disease].
    Quinkler M.
    Med Klin Intensivmed Notfmed; 2012 Sep 07; 107(6):454-9. PubMed ID: 22907517
    [Abstract] [Full Text] [Related]

  • 17. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M, Gryczyńska M, Sowińska A, Sowiński J.
    Przegl Lek; 2011 Sep 07; 68(2):96-102. PubMed ID: 21751518
    [Abstract] [Full Text] [Related]

  • 18. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS, Rushworth RL, Clifton PM, Torpy DJ.
    BMC Endocr Disord; 2015 Oct 24; 15():61. PubMed ID: 26500000
    [Abstract] [Full Text] [Related]

  • 19. Steroid replacement in Addison's disease and in subjects adrenalectomized for Cushing's disease: comparison of various glucocorticoids.
    Khalid BA, Burke CW, Hurley DM, Funder JW, Stockigt JR.
    J Clin Endocrinol Metab; 1982 Sep 24; 55(3):551-9. PubMed ID: 6284785
    [No Abstract] [Full Text] [Related]

  • 20. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
    Aanderud S, Myking OL, Bassøe HH.
    Acta Endocrinol (Copenh); 1982 Aug 24; 100(4):588-94. PubMed ID: 6289586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.